FDA approves use of new Pancreatic Cancer Drug

The Food and Drug Administration (FDA) permitted the use a new pancreatic cancer drug, but has spread awareness among patients and prescribers to note down the list of warnings that comes along with the product.

This is a major advancement because pancreatic cancer is regarded as the most fatal cancers in the world, and its diagnose is very difficult to find early and only few treatment options are available.

Director of the Office of Hematology and Oncology Products and part of the FDA's Center for Drug Evaluation and Research, Dr. Richard Pander said, “Many FDA staffs who review drug applications are clinicians as well, so it's especially rewarding when we are able to expedite access to new treatments for patients with unmet needs”.

YouTube under fire for the way it handled its biggest stars

YouTube's latest creation ‘YouTube Red’ for generating even more revenue is under fire for the way the company has dealt with its biggest stars. A YouTube Red subscription is going to free subscribers from having to bear pre-roll advertisements from their favorite YouTube channels for a price.

Subscribers will have to pay $9.99 a month, and they will get ad-free YouTube videos, Google Play Music availability, exclusive original content from YouTube official Creator partners, such as PewDiePie, and many other unspecified perks.

While talking about the service, Robert Kyncl, YouTube's chief business officer, said that 99.9% of the content on YouTube will remain free, like always.

Walgreens won’t open any new Theranos Inc. blood-testing centers until company resolves technology issues

According to a Walgreens official, Walgreens Boots Alliance Inc. is not going to open any new Theranos Inc. blood-testing centers until questions about its technology are resolved by the startup company. A team from the drugstore chain met senior Theranos executives on Thursday at the startup’s headquarters in Palo Alto, Calif.

Planned Parenthood dubs record request politically motivated

Planned Parenthood is having a really bad time. Now, the fight over Medicaid funding for Planned Parenthood has moved to Texas, where Gov. Greg Abbott has asked to end the funding for the organization. Texas health department investigators also reached Planned Parenthood health centers in different places to see documents.

Planned Parenthood South Texas has been asked to provide five years of records, which have any case of patient who has undergone abortion and any part of the fetus has been preserved for research use and also, has been billed to Medicaid.

Texas Tech's Breast Center of Excellence disagrees with new screening guidelines

Texas Tech's Breast Center of Excellence disagrees with the American Cancer Society’s latest breast cancer screening guidelines. It is telling women across the Panhandle to not follow them. The American Cancer Society released new guidelines earlier this week.

The guidelines suggested that women at ‘average risk’ of breast cancer must start annual mammograms at 45, which is 5 years later than earlier recommended. According to local doctors, the delay of 5 years may have serious implications for women in the Panhandle.

Black Death Bacterium Older than thought

The Black Death is considered one of the most devastating pandemics in the history of humankind. More than 50 million individuals lost their lives due to the pandemic, which swept through Europe in 1347. Now, DNA from Bronze Age human skeletons has linked the emergence of plague to time as early as 3,000 BC. The DNA suggested that the plague first emerged thousands of years than previously thought and did not spread ferociously.

Yersinia pestis is the bacterium responsible for the Black Death and a number of other plagues in human history. The historic analysis of the disease’s spread and symptoms is same as that of modern outbreaks of bubonic plague.

Pages

News in Focus

Coforge Limited Share Price Target at Rs 1,900: Motilal Oswal Financial Services

Motilal Oswal Financial Services has reiterated its BUY recommendation on Coforge with a target price of Rs 1,900, implying an upside potential of nearly 30% from the current market price of Rs 1,4

RateGain Travel Technologies Share Price Target at Rs 1,000: Anand Rathi

RateGain Travel Technologies has emerged as one of the most compelling growth stories within India's travel technology ecosystem, according to Anand Rathi.

Why Rodrygo Still Looks Like the Forward Premier League Giants Keep Circling

Rodrygo transfer rumors have lasted because the football logic is stronger than the gossip cycle.

Indonesia Football 2026: Timnas Progress, Fans, and Asian Ambition

The Indonesia national football team enters 2026 with heavier expectations, even after missing the expanded World Cup.

Musk vs. Tang: A Public Reckoning Over China's AI Horizon

China's race to close the AI gap with the United States is no longer theoretical — it's a matter of months.